Connection
Thomas Jensen to Follow-Up Studies
This is a "connection" page, showing publications Thomas Jensen has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.023 |
|
|
|
-
Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB. Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial. Diabetes Care. 2018 08; 41(8):1663-1671.
Score: 0.019
-
Deckert T, Yokoyama H, Mathiesen ER, Rønn B, Jensen TJ, Feldt-Rasmussen BF, Borch-Johnsen K, Jensen JS. [Microalbuminuria as predictor of atherosclerotic cardiovascular disease in IDDM]. Ugeskr Laeger. 1997 May 12; 159(20):3010-4.
Score: 0.004